Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Down Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 23fludarabine 15fludarabine phosphate 10Methotrexate 10blinatumomab 9Whole-Body Irradiation 9Vincristine 7Specimen Handling 7Dexamethasone 7merphos 6Tacrolimus 6Mycophenolic Acid 6Stem Cell Transplantation 5Peripheral Blood Stem Cell Transplantation 5Mesna 5Mercaptopurine 5Melphalan 5Leukapheresis 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Cytarabine 5Cyclosporine 5Biopsy 5pegaspargase 4Prednisone 4Magnetic Resonance Spectroscopy 4Etoposide 4Calcium Dobesilate 4Busulfan 4prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Thioguanine × 30 days × Clear all
NCT01190930 2026-05-28

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Children's Oncology Group

Phase 3 Completed
9,350 enrolled 51 charts
LymphoidOther hematologic neoplasm

Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡